Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Zamuner

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Clinical Pharmacology and Therapeutics|March 26, 2010
Adaptive-optimal design in PET occupancy studiesS Zamuner, V L Di Iorio, J Nyberg, et al.
Metabolic Syndrome and Related Disorders|October 30, 2014
Are metabolic syndrome and its components associated with 5-year mortality in chronic obstructive pupmonary disease patients?Suzana E Tanni, Amanda T S Zamuner, Liana S Coelho, et al.
Lupus|April 9, 2016
Safety, tolerability, efficacy and pharmacodynamics of the selective JAK1 inhibitor GSK2586184 in patients with systemic lupus erythematosusL Kahl, J Patel, M Layton, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|August 7, 2008
Suppressive effects of nitric oxide-releasing prednisolone NCX-1015 on the allergic pleural eosinophil recruitment in ratsM S S Oliveira, E de O Barreto, S Zamuner, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Clinical Pharmacology and Therapeutics|March 26, 2010
Adaptive-optimal design in PET occupancy studiesS Zamuner, V L Di Iorio, J Nyberg, et al.
Metabolic Syndrome and Related Disorders|October 30, 2014
Are metabolic syndrome and its components associated with 5-year mortality in chronic obstructive pupmonary disease patients?Suzana E Tanni, Amanda T S Zamuner, Liana S Coelho, et al.
Lupus|April 9, 2016
Safety, tolerability, efficacy and pharmacodynamics of the selective JAK1 inhibitor GSK2586184 in patients with systemic lupus erythematosusL Kahl, J Patel, M Layton, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|August 7, 2008
Suppressive effects of nitric oxide-releasing prednisolone NCX-1015 on the allergic pleural eosinophil recruitment in ratsM S S Oliveira, E de O Barreto, S Zamuner, et al.
Pageof 3